Add To Watchlist
Share URL
About The Company
Description
Hangzhou Tigermed Consulting Co.
Read More
Overview
Value
10
Growth
79
Health
77
Management
93
Analyst Opinion
80
Total
68
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a low level of debt
- Low risk of bankruptcy
- Has strong financial health
- Liked by analysts
- Has strong dividend growth
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings growth has slowed down recently
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Price-to-earnings ratio of 37.8 is higher than the market average (19.6x)
- Very safe dividend
Market Peers
300347.SZ
Key Figures
PE Ratio (TTM)
37.76
Margin Of Safety (DCF)
-58.56%
Revenue Growth (5 Year Average)
20.43%
Ratings Consensus
Buy
Share Buybacks
-4.99%
Dividend Yeild (TTM)
0.48%
Valuation
Value Score
10
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 42.1 CNY ✘
Current Price: 118.1 CNY
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
37.76x
Free Cashflow Yeild
1.10%
PE/Earnings Growth
0.75
Price/Book
4.49x
Growth
Growth Score
79
- ✔ 5 Year Average Revenue growth of 20.43% is higher than the market average (10.97%)
- ✔ Revenue growth has improved this yeara
- ✔ 5 Year Average Earnings growth of 24.59% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 20.85% is higher than the market average (12.35%)
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
20.43%
Earnings Growth
24.59%
Cashflow Growth
20.85%
Health
Health Score
77
Altman Z Score
13.45
Piostroski Score
4.00
Debt/Equity
0.07x
Current Assets/Liabilities
4.50x
Free Cashflow/Total Debt
0.89x
Debt/Capital
0.11x
Dividend
Secure Dividend Score
80
- ✔ Very safe
- ✔ Long term dividend payout ratio of 20.95% is considered good
- ✔ Payout ratio (TTM) of 17.68% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of 0.48% is less than the market average (1.85%)
- ✘ Dividend growth has been slowing recently
Dividend Yeild
0.48%
Dividend Growth
4.77%
Payout Ratio (Earnings)
17.68%
Payout Ratio (Cashflow)
43.44%
Management
Management Score
93
- ✔ Has issued new shares to finance growth when share price is high
- ✔ Has returned higher dividends when earnings have risen
- ✔ Return-on-equity of 15.41% is higher than the market average (15%)
- ✔ Return-on-capital-employed of 13.65% is higher than the market average (10%)
- ✘ Has a history of diluting shareholders to finance activity
Average Buybacks/Dilution
-4.99%
Recent Buybacks/Dilution
-2.83%
5 Year Price Volitility
60.21%
Return On Assets
11.76%
Return On Capital Employed
13.65%
Return On Equity
15.41%
Return On Free Cashflow
331.62%
Return On Investments
29.40%
Analysts
Analyst Opinion
80
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Hangzhou Tigermed Consulting Co., Ltd.
Currency
CNY
Beta
0.811374
Vol Avg
6647884
Ceo
Cik
Cusip
Exchange
Shenzhen
Full Time Employees
8326
Industry
Diagnostics & Research
Sector
Healthcare
Ipo Date
2012-08-17
Address
F18, Building A – Shengda Science Park
City
Hangzhou
State
Country
CN
Zip
310051
Phone
86 57 1288 87227
All financial data provided by FMP